Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 101 M84 M84 M79 M83 M 330 M Research & development ————— — Operating income 532 M237 M483 M354 M403 M 1.48 B Non-Operating Income, Total 6 M8 M-24 M22 M-15 M -9 M Interest expense, net of interest capitalized 107 M110 M112 M138 M144 M 504 M Non-Operating Income, excl. Interest Expenses -107 M-110 M-127 M-132 M-144 M -513 M Unusual income/expense 6 M8 M-9 M16 M-15 M 0 Pretax income 565 M229 M458 M320 M333 M 1.34 B Equity in earnings 103 M94 M96 M89 M89 M 368 M Taxes 30 M16 M30 M14 M8 M 68 M Non-controlling/minority interest 408 M253 M421 M344 M202 M 1.22 B After tax other income/expense -19 M-12 M-16 M33 M-30 M -25 M Net income before discontinued operations 84 M-40 M7 M-40 M123 M 50 M Discontinued operations 38 M70 M76 M102 M-103 M 145 M Net income 84 M30 M83 M62 M20 M 195 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 92 M30 M86 M66 M20 M 202 M Basic earnings per share (Basic EPS) ————— — Diluted earnings per share (Diluted EPS) ————— — Average basic shares outstanding ————— — Diluted shares outstanding ————— — EBITDA 794 M472 M713 M609 M646 M 2.44 B EBIT 532 M237 M483 M353 M403 M 1.48 B Cost of revenue 10.76 B9.76 B10.59 B9.33 B11.49 B 41.16 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 262 M235 M230 M256 M243 M 964 M